Real-Time Post-Market Signal For Enhanced Surveillance ODT-2026-133586
Summary
AI-generated · Mar 19, 2026FDA seeks market research on capabilities to deliver real-time or near-real-time signals to support post-market surveillance for regulated products. Determine whether commercial providers currently offer, or could provide, timely signals or alerts related to events affecting regulated products—such as safety events, product quality issues, supply disruptions, or other significant public health signals—and how these feeds might be integrated with FDA systems.
The effort aims to understand available capabilities, potential technical integration approaches, and possible cost models for providing real-time signal feeds. This is for market research only and does not constitute a solicitation or a commitment to issue a solicitation in the future.
The U.S. Food and Drug Administration (FDA) is conducting market research to better understand industry capabilities related to providing real-time or near-real-time signals that may support FDA s post-market surveillance activities for regulated products. FDA is interested in learning whether commercial organizations currently provide, or could provide, timely signals or alerts related to events affecting regulated products, such as safety events, product quality issues, supply disruptions, or other significant public health signals. Information obtained through this Request for Information (RFI) will assist the Government in determining the availability of industry capabilities, potential technical integration approaches, and possible cost models associated with providing real-time signal feeds to FDA systems. This RFI is issued for market research purposes only and does not constitute a solicitation for proposals or a commitment by the Government to issue a solicitation in the future.
From Sources Sought posted on Mar 18, 2026The U.S. Food and Drug Administration (FDA) is conducting market research to better understand industry capabilities related to providing real-time or near-real-time signals that may support FDA s post-market surveillance activities for regulated products. FDA is interested in learning whether commercial organizations currently provide, or could provide, timely signals or alerts related to events affecting regulated products, such as safety events, product quality issues, supply disruptions, or other significant public health signals. Information obtained through this Request for Information (RFI) will assist the Government in determining the availability of industry capabilities, potential technical integration approaches, and possible cost models associated with providing real-time signal feeds to FDA systems. This RFI is issued for market research purposes only and does not constitute a solicitation for proposals or a commitment by the Government to issue a solicitation in the future.
From Sources Sought posted on Apr 06, 2026Notice history
2-
-
Sources Sought LATEST Posted Apr 06, 2026No changes from previous notice
Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA